Skip to content

The effect of sacral nerve stimulation on the treatment of patients with constipation resulting from difficulty in evacuating the rectum

Prospective randomised double-blind placebo-controlled crossover study of sacral nerve stimulation in patients with severe rectal evacuatory dysfunction and rectal hyposensitivity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN25945941
Enrollment
20
Registered
2011-07-05
Start date
2006-08-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation Digestive System Other functional intestinal disorders

Interventions

1. Anorectal physiology: this will take 30 minutes
patients selected for the study will be required to have full anorectal physiology investigations. This will consist of anal manometry, rectal sensory thresholds, pudendal nerve stimulation, endoanal
subjects will have rectal sensory thresholds to balloon distension after two weeks, at the crossover period, and at the end of the trial at 4 weeks. This consists of a balloon on the end of a catheter

Sponsors

Queen Mary, University of London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 - 65 years, either sex 2. Incomplete and/or assisted evacuation 3. Idiopathic (no rectal surgery, no spinal and overt neurological history) 4. Failed maximal conventional therapy 5. Normal colonic transit and rectal diameter 6. No significant mechanical obstructive abnormality on proctography 7. Unable to evacuate greater than 60% contrast in 3 minutes 8. Rectal hyposensation (based 2/3 abnormal values of first constant sensation [FCS], defecatory desire [DDV] and maximum tolerable volume [MTV] to balloon distension)

Exclusion criteria

Exclusion criteria: 1. Inability to provide informed consent 2. Severe concomitant medical conditions precluding randomisation to operative treatment 3. Neurological diseases such as diabetic neuropathy, multiple sclerosis and parkinson's disease 4. Other medical conditions precluding stimulation: e.g. bleeding disorders, certain cardiac pacemakers 5. Congenital anorectal anomalies or absence of native rectum due to surgery 6. Present evidence of external full thickness rectal prolapse 7. Previous rectal surgery (rectopexy/resection) done less than 12 months ago (24 months for cancer) 8. Stoma in situ 9. Chronic bowel disease such as inflammatory bowel disease, chronic uncontrolled diarrhoea 10. Anatomical limitations that would prevent successful placement of electrodes 11. Pregnancy or intention to become pregnant 12. Previous experience of sacral nerve stimulation (SNS)

Design outcomes

Primary

MeasureTime frame
1. Normalisation of rectal sensory thresholds to balloon distension (first constant sensation, defaecatory desire volume, maximum tolerable volume) 2. Improvement in Cleveland Clinic Constipation scores 3. Increase in percentage of complete bowel movements from the bowel diaries Measured at baseline then after two weeks and then after 4 weeks.

Secondary

MeasureTime frame
Improvements in the following criteria during the stimulation period: 1. Quality of life using validated methods of assessing health related quality of life (SF36) and gastrointestinal related quality of life (GIQoL) 2. Data from bowel diaries Measured at baseline then after two weeks and then after 4 weeks.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026